
    
      The objectives of the study are to assess FX005, as compared to placebo control, for:

        -  Safety and tolerability

        -  Analgesic effect

        -  Pharmacokinetics

      Analgesic effect will be assessed using the Western Ontario & McMaster University
      Osteoarthritis Index (WOMAC), the Measure of Intermittent and Constant Osteoarthritis Pain
      (ICOAP) questionnaire, and patient and clinical observer global assessments.
    
  